Showing results (21-30 of 211) with videos related to
Sort By:
Pageof 22
The Canadian Journal of Cardiology|December 28, 2020
Key Issues in the Statistical Interpretation of Randomized Clinical TrialsJames M BrophyThe Canadian Journal of Cardiology|March 29, 2021
Bayesian Analyses of Cardiovascular Trials-Bringing Added Value to the TableJames M BrophyJAMA Internal Medicine|June 2, 2020
Bayesian Interpretation of the EXCEL Trial and Other Randomized Clinical Trials of Left Main Coronary Artery RevascularizationJames M BrophyAnnals of Internal Medicine|August 1, 2022
In HF, SGLT2 inhibitors reduce HF hospitalizations at up to 2 yJames M BrophyIndian Journal of Medical Ethics|September 9, 2016
Vioxx redux - or how I learned to worry about industry-sponsored clinical trialsJames M BrophyContemporary Clinical Trials|July 10, 2026
Understanding unexpected results from randomized clinical trials - Does coffee reduce atrial fibrillation recurrences?James M BrophyAtherosclerosis|August 2, 2015
Utility of a genetic risk score to predict recurrent cardiovascular events 1 year after an acute coronary syndrome: A pooled analysis of the RISCA, PRAXY, and TRIUMPH cohortsChristopher Labos, Sara C Martinez, Rui Hao Leo Wang, et al.Plos One|August 22, 2014
Impact of ECG findings and process-of-care characteristics on the likelihood of not receiving reperfusion therapy in patients with ST-elevation myocardial infarction: results of a field evaluationKevin A Brown, Laurie J Lambert, James M Brophy, et al.The Canadian Journal of Cardiology|February 2, 2006
Statin wars following coronary revascularization--evidence-based clinical practice?James M Brophy, Vania CostaPageof 22